Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional) (PAR-23-042)

Sponsor: National Institutes of Health

Due Date: March 09, 2023. All applications are due by 5:00 PM local time of applicant organization.

Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and ADRD (U24 Clinical Trial Optional) (RFA-AT-23-008)

Sponsor: National Center for Complementary and Integrative Health, National Institute on Aging

Due Date: January 10, 2023. All applications are due by 5:00 PM local time of applicant organization.

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-NS-23-049)

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-23-050)

Sponsor: National Institute of Neurological Disorders and Stroke

NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (PAR-23-057)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) (PAR-23-072)

Sponsor: Food and Drug Administration

Due Date: Multiple due dates; see announcement.

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (PAR-23-054)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) (PAR-23-053)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-24-022)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (PAR-23-046)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) (PAR-23-047)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Alzheimer's Association Zenith Fellows Award

Sponsor: Alzheimer's Association

Award: Each award is limited to $450,000 total funding (direct and indirect costs) over a period of up to three years.

Due Date: Letter of Intent Deadline: Jan. 20, 2023, 5 p.m. (ET)

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) (PA-23-044)

Sponsor: National Institutes of Health

Due Date: See announcement.

Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and AD Related Dementias (U24 Clinical Trial Optional) (RFA-AT-23-006)

Sponsor: National Center for Complementary and Integrative Health, National Institute on Aging

Award: In FY2023, NIA intends to commit $500,000 in total cost and will support 1 award focusing on Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD).

Due Date: January 10, 2023. All applications are due by 5:00 PM local time of applicant organization.

Notice of Intent to Publish an FOA for NIA’s Alzheimer's Disease and Alzheimer's Disease-Related Dementias Real-World Data Platform Initiative (U54 Clinical Trial Required) (NOT-AG-22-044)

Sponsor: National Institute on Aging

Award: NIA intends to commit approximately $50 million in total costs per year starting in fiscal year 2024, for up to 6 years, to fund one award.

Due Date: Estimated Publication Date of Funding Opportunity Announcement: January 09, 2023.